Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26

Clinical and Experimental Immunology

Volumn 121, Issue 2, 2000, Pages 187-192

  Katoh, N ^a   Hirano, S ^a   Suehiro, M ^a   Ikenaga, K ^a   Yamashita, T ^a,b   Sugawara, N ^a,b   Yasuno, H ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Atopic dermatitis; Plasma; Soluble CD26; Soluble CD30

Indexed keywords

CD30 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCORING SYSTEM; TH2 CELL;

ADOLESCENT; ADULT; ANTIGENS, CD26; ANTIGENS, CD30; BIOLOGICAL MARKERS; CHILD; DERMATITIS, ATOPIC; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKINS; L-LACTATE DEHYDROGENASE; MALE; RECEPTORS, INTERLEUKIN-2; SEVERITY OF ILLNESS INDEX; SOLUBILITY; TH1 CELLS; TH2 CELLS;

EID: 0033847455     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01286.x     Document Type: Article

References (36)

1. Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic disease
2. Pathogenesis of atopic dermatitis
3. Atopic dermatitis: Recent trends in pathogenesis and therapy
4. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
5. The expanding universe of T-cell subsets: Th1, Th2 and more
6. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals
7. Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis
8. Differential in situ cytokine expression in acute versus chronic atopic dermatitis
9. Biphasic response against aeroallergens in atopic dermatitis showing a switch from an initial T(H2) response to a T(H1) response in situ: An immunocytochemical study
10. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
11. Development of allergen-specific T-cell memory in atopic and normal children
12. Decreased frequency of interferon-γ- and interleukin-2-producing cells in patients with atopic disease measured at the single cell level
13. Molecular cloning and expression of a new member of the nerve growth factor family that is characteristic for Hodgkin's disease
14. Production of a monoclonal antibody specific for Hodgkin and Steinberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
15. + T cells producing Th2-type cytokines
16. CD30 and type 2 T helper (Th2) responses
17. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD)
18. Soluble CD30 in pediatric patients with atopic dermatitis
19. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis
20. In vivo relevance of CD30 in atopic dermatitis
21. Soluble cytokine receptor CD30 in atopic disorders: A case control study
22. CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-γ
23. Cell surface characterization of T lymphocytes and allergen-specific T cell clones: Correlation of CD26 expression with T(H1) subsets
24. Diagnostic features of atopic dermatitis
25. Scoring atopic dermatitis: The simpler the better?
26. In vivo expression of IL-12 and IL-13 in atopic dermatitis
27. Lesional expression of interferon-gamma in atopic eczema
28. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions
29. The role of eosinophils in the pathogenesis of atopic dermatitiseosinophil granule proteins as markers of disease activity
30. IgE enhances mouse mast ceil FcεRI expression in vitro and in vivo: Evidence for a novel amplification mechanism in IgE-dependent reactions
31. IgE enhances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: Synergistic effect of IL-4 and IgE on human mast cell Fcε receptor I expression and mediator release
32. Function and regulation of FcεRI expression on monocytes from non-atopic donors
33. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, FcεRI
34. The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy
35. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression
36. Histamine inhibits the production of interleukin-12 through interaction with H2 receptor